Multinational healthtech start-up Shivom has raised more than $25 million in a presale of its OmiX token, aimed at funding its blockchain-backed technology. Shivom offers users the chance to have their genome sequenced, then uploaded on to a blockchain where it will be for sale to global healthcare providers offering personalised treatments, as well as research organisations and medical institutes, trying to find cures for genetic diseases.
Multinational healthtech start-up Shivom has raised $25m in a presale of its OmiX token, aimed at funding its blockchain-backed technology. Shivom offers users the chance to have their genome sequenced, then uploaded on to a blockchain where it will be for sale to global healthcare providers offering personalised treatments, as well as research organisations and medical institutes, trying to find cures for genetic diseases.